Article Type
Case Report
Published
This article presents a case demonstrating the use of combination immunotherapy with pembrolizumab and lenvatinib in a patient with recurrent and metastatic endometrial cancer.
Case Report
This article presents a case demonstrating the use of combination immunotherapy with pembrolizumab and lenvatinib in a patient with recurrent and metastatic endometrial cancer.
Original Research
This study aims to determine the percentage of patients whose initial luteinizing hormone-releasing hormone agonists prescription was renewed during follow-up, how many changed formulation and how their quality of life evolved.
Review
The aim of this paper is to discuss current knowledge on radiation-induced dermatitis and propose targets for the prevention/treatment of this
condition. On these bases, the characteristics of the ‘ideal’
compound to address this side effect will be described.
Review
This article discusses the current management of this rare entity and provide an overview of the most relevant molecular findings, whilst illustrating the potential value that prescreening panels can offer, searching for actionable targets (MSI/dMMR, PD-L1, BRAFv600E) to guide therapy with promising agents that could fill a void in this disease.